Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

Medically reviewed by John Carew, MD Fact checked by Nick Blackmer Allergies and sinus infections have overlapping symptoms, but are caused by different things. Allergies happen when your immune ...

A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...

Nasal sprays are the quick fix for stuffy noses, the secret weapon against allergy season, and a lifesaver when you need to ...

Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...

2,3 “Chronic rhinosinusitis with nasal polyps negatively impact patients’ daily ... and change from baseline in bi-weekly mean nasal congestion, measured by the participant-reported Nasal Congestion ...